Stockscreener 앱 받기
21.36
0.14%
-0.03
시간 외 거래:
21.36
전일 마감가:
$21.39
열려 있는:
$21.38
하루 거래량:
1.26M
Relative Volume:
0.44
시가총액:
$2.10B
수익:
$221.08M
순이익/손실:
$-2.92M
주가수익비율:
-647.27
EPS:
-0.033
순현금흐름:
$5.89M
1주 성능:
+0.09%
1개월 성능:
+11.54%
6개월 성능:
+128.69%
1년 성능:
+101.32%
1일 변동 폭
$21.34
$21.43
1주일 범위
$21.29
$21.55
52주 변동 폭
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
명칭
Avadel Pharmaceuticals Plc
전화
636-449-1830
주소
10 EARLSFORT TERRACE, DUBLIN 2
AVDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.36 | 2.10B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | 개시 | Wells Fargo | Equal Weight |
| 2025-07-18 | 재개 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-06-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-03-05 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-05 | 재확인 | Needham | Buy |
| 2024-03-05 | 재확인 | Oppenheimer | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2022-11-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-28 | 재개 | Craig Hallum | Buy |
| 2022-05-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-23 | 개시 | Needham | Buy |
| 2020-07-31 | 개시 | Oppenheimer | Outperform |
| 2020-07-21 | 개시 | SVB Leerink | Outperform |
| 2020-06-30 | 개시 | H.C. Wainwright | Buy |
| 2020-04-03 | 개시 | Jefferies | Buy |
| 2020-03-12 | 개시 | Stifel | Buy |
| 2020-02-26 | 개시 | Piper Sandler | Overweight |
| 2020-01-30 | 개시 | Craig Hallum | Buy |
| 2019-06-14 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
모두보기
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plcAVDL - PR Newswire
Goldman Sachs (EPT)38.5bAVADEL PHARMACEUTICALS PLC - Research Tree
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
J.P. Morgan Securities discloses position in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.24% stake in Avadel Pharmaceuticals - Investing.com
Geode Capital discloses 2.25% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Bank of America discloses 2% stake in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley reports trading activity in Avadel Pharmaceuticals shares - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities By Investing.com - Investing.com Australia
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Alkermes, Avadel Pharmaceuticals merger gets HSR clearance in US - MLex
Avadel Pharmaceuticals Acquisition by Alkermes Advances - TradingView
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Trium Capital discloses 1.29% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com UK
FIL Limited discloses 2.9% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
REGFIL Limited Avadel Pharma plcForm 8.3AVADEL PHARMACEUTICALS PLC - TradingView
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals - Investing.com
Discipline and Rules-Based Execution in AVDL Response - news.stocktradersdaily.com
Avadel Pharmaceuticals PLC (AVDL) - MSN
Is Avadel Pharmaceuticals Still Attractive After a 113.4% One Year Surge in 2025? - Sahm
How Recent Deal Developments Are Reshaping The Avadel Pharmaceuticals Investment Story - Yahoo Finance
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Has Avadel’s 115% Rally in 2024 Already Priced In Its Narcolepsy Breakthrough? - Yahoo Finance
Avadel Pharmaceuticals plc and Alkermes plc Announce Proposed Transaction for Acquisition - Quiver Quantitative
Announcement relating to despatch of Rule 15 proposal - The Manila Times
Avadel (NASDAQ: AVDL) sends Rule 15 proposal to equity holders in Alkermes deal - Stock Titan
Avadel Pharmaceuticals Plc (AVDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.48%
0.09%
자본화:
|
볼륨(24시간):